Taxotere Epiphora Lawsuit Filed Over Excessively Watery Eyes
Sanofi now faces nearly 170 Taxotere epiphora lawsuits from breast cancer patients who say they were left with excessive tearing and watery eyes after the chemotherapy treatments.
Sanofi now faces nearly 170 Taxotere epiphora lawsuits from breast cancer patients who say they were left with excessive tearing and watery eyes after the chemotherapy treatments.
The findings of a new study indicate Taxotere and similar chemotherapy drugs can significantly increase the risk of epiphora and optic neuropathy.
A generic Taxotere lawsuit filed against Sandoz claims the manufacturer failed to warn patients that the breast cancer chemotherapy drug could cause permanent eye damage.